M

Myonexus Therapeutics, Inc.

12 employees

Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy types.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$60M

from 3 investors over 3 rounds

M

Myonexus Therapeutics, Inc. raised $60M on May 8, 2018

Investors: Sarepta Therapeutics

M

Myonexus Therapeutics, Inc. raised $2.5M on September 29, 2017

Investors: CincyTech USA and Rev1 Ventures

FAQ